Insider · CIK 0001644162

Nicaise Claude

Reports to the SEC for 4 companies · BETHESDA, MD

sec.gov

Transactions

Companies

Filings

CIK

0001644162

Forms 4 and 5

Insider transactions

42 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-07-15	GANXGain Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+25K sh	—	—	25,000
2026-06-04	SRPTSarepta Therapeutics, Inc.A Award	Director	AAward	+16.9K sh	—	—	48,407
2026-01-29	SRPTSarepta Therapeutics, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+10.5K sh	$13.71	+$144K	38,312
2026-01-29	SRPTSarepta Therapeutics, Inc.F Tax Payment	Director	FTax Payment	−6,780 sh	$21.23	−$144K	31,532
2026-01-29	SRPTSarepta Therapeutics, Inc. · Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−10.5K sh	—	—	0
2025-06-24	GANXGain Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+15K sh	—	—	15,000
2025-05-23	FLNAFILANA THERAPEUTICS, INC. · Stock Option (Right to Buy)A Award	Director	AAward	+26.5K sh	—	—	26,500
2025-03-12	SRPTSarepta Therapeutics, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+9,746 sh	$25.18	+$245K	30,303
2025-03-12	SRPTSarepta Therapeutics, Inc.S Sale	Director	SSale	−2,491 sh	$99.64	−$248K	27,812
2025-03-12	SRPTSarepta Therapeutics, Inc. · Stock Options (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−9,746 sh	—	—	0
2025-03-10	SRPTSarepta Therapeutics, Inc.A Award	Director	AAward	+2,383 sh	—	—	20,557
2025-03-10	SRPTSarepta Therapeutics, Inc. · Stock Options (right to buy)A Award	Director	AAward	+4,792 sh	—	—	20,557
2024-06-24	GANXGain Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+15K sh	—	—	15,000
2024-05-09	FLNAFILANA THERAPEUTICS, INC. · Stock Option (Right to Buy)A Award	Director	AAward	+10K sh	—	—	10,000
2024-03-01	SRPTSarepta Therapeutics, Inc.A Award	Director	AAward	+1,846 sh	—	—	18,174
2024-03-01	SRPTSarepta Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+3,679 sh	—	—	3,679
2023-12-06	FLNAFILANA THERAPEUTICS, INC. · Stock Option (Right to Buy)A Award	Director	AAward	+20K sh	—	—	20,000
2023-06-23	GANXGain Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+10.5K sh	—	—	10,500
2023-03-16	CMMBChemomab Therapeutics Ltd. · Option to Purchase American Depositary SharesA Award	Director	AAward	+6,857 sh	—	—	6,857
2023-03-16	CMMBChemomab Therapeutics Ltd. · Option to Purchase American Depositary SharesA Award	Director	AAward	+6,820 sh	—	—	6,820
2023-03-16	CMMBChemomab Therapeutics Ltd. · Option to Purchase American Depositary SharesA Award	Director	AAward	+11.9K sh	—	—	11,884
2023-03-06	SRPTSarepta Therapeutics, Inc.A Award	Director	AAward	+1,523 sh	—	—	16,328
2023-03-06	SRPTSarepta Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+3,257 sh	—	—	3,257
2022-09-20	GANXGain Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+10.5K sh	—	—	10,500
2022-03-07	SRPTSarepta Therapeutics, Inc.A Award	Director	AAward	+2,953 sh	—	—	14,805
2022-03-07	SRPTSarepta Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+5,077 sh	—	—	5,077
2022-03-07	CMMBChemomab Therapeutics Ltd. · Option to Purchase American Depositary SharesA Award	Director	AAward	+6,820 sh	—	—	6,820
2021-04-19	CMMBChemomab Therapeutics Ltd. · Option to Purchase American Depositary SharesA Award	Director	AAward	+11.9K sh	—	—	11,884
2021-04-19	CMMBChemomab Therapeutics Ltd. · Option to Purchase American Depositary SharesA Award	Director	AAward	+11.9K sh	—	—	11,884
2021-03-03	SRPTSarepta Therapeutics, Inc.A Award	Director	AAward	+2,726 sh	—	—	11,852
2021-03-03	SRPTSarepta Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+5,518 sh	—	—	5,518
2020-02-28	SRPTSarepta Therapeutics, Inc.A Award	Director	AAward	+2,075 sh	—	—	9,126
2020-02-28	SRPTSarepta Therapeutics, Inc. · Stock option (right to buy)A Award	Director	AAward	+3,685 sh	—	—	3,685
2019-03-04	SRPTSarepta Therapeutics, Inc.A Award	Director	AAward	+1,633 sh	—	—	7,051
2019-03-04	SRPTSarepta Therapeutics, Inc. · Stock option (right to buy)A Award	Director	AAward	+3,213 sh	—	—	3,213
2018-03-05	SRPTSarepta Therapeutics, Inc.A Award	Director	AAward	+3,418 sh	—	—	5,418
2018-03-05	SRPTSarepta Therapeutics, Inc. · Stock option (right to buy)A Award	Director	AAward	+4,820 sh	—	—	4,820
2017-03-10	SRPTSarepta Therapeutics, Inc.A Award	Director	AAward	+1,000 sh	—	—	2,000
2017-03-10	SRPTSarepta Therapeutics, Inc. · Non-Qualified Stock Option (right to buy)A Award	Director	AAward	+12.4K sh	—	—	12,350
2016-02-29	SRPTSarepta Therapeutics, Inc.A Award	Director	AAward	+1,000 sh	—	—	1,000
2016-02-29	SRPTSarepta Therapeutics, Inc. · Non-Qualified Stock Option (right to buy)A Award	Director	AAward	+10.5K sh	—	—	10,500
2015-06-02	SRPTSarepta Therapeutics, Inc. · Non-Qualified Stock Option (right to buy)A Award	Director	AAward	+9,746 sh	—	—	9,746

Recent filings

Accepted (ET)
Jul 174
Nicaise Claude0001104659-26-084438
SEC(opens sec.gov)
Jun 54
Nicaise Claude0001193125-26-260250
SEC(opens sec.gov)
Jan 294
Nicaise Claude0001193125-26-029895
SEC(opens sec.gov)
Jun 254
Nicaise Claude0001641172-25-016535
SEC(opens sec.gov)
May 274
Nicaise Claude0001437749-25-018497
SEC(opens sec.gov)
Mar 134
Nicaise Claude0000950170-25-039037
SEC(opens sec.gov)
Mar 114
Nicaise Claude0000950170-25-037522
SEC(opens sec.gov)
Jun 264
Nicaise Claude0001493152-24-025336
SEC(opens sec.gov)
May 134
Nicaise Claude0001437749-24-016227
SEC(opens sec.gov)
Mar 54
Nicaise Claude0000950170-24-026617
SEC(opens sec.gov)
Dec 84
Nicaise Claude0001437749-23-034025
SEC(opens sec.gov)
Jun 264
Nicaise Claude0001209191-23-039720
SEC(opens sec.gov)
Mar 234
Nicaise Claude0001178913-23-001113
SEC(opens sec.gov)

Companies

Address

C/O GAIN THERAPEUTICS, INC. 4800 MONTGOMERY LANE, SUITE 220

BETHESDA, MD, 20814